Form 4: Oscar Health Co-Founder and Vice Chairman, Joshua Kushner, Increases Stake Through Multiple Purchases

Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, has increased his indirect holdings in the company through multiple purchases of Class A Common Stock between November 11th and November 13th, 2024.

Summary

• Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, indirectly acquired shares of Class A Common Stock through Thrive Capital Partners VII Growth, L.P. and Claremount VII Associates, L.P.
• The purchases occurred over three days, from November 11th to November 13th, 2024.
• On November 11th, 276,040 shares were purchased at a weighted average price of $13.5779.
• On November 12th, 420,819 shares were purchased at a weighted average price of $13.6772.
• On November 13th, 358,619 shares were purchased at a weighted average price of $13.7369.
• The total number of shares indirectly held by Mr. Kushner increased to 5,810,700 as a result of these transactions.
• The shares were purchased in multiple transactions at varying prices within the ranges specified, all in accordance with Rule 10b-18.

Sentiment

Score: 6

Explanation: The document indicates increased insider ownership, which is generally viewed positively, but it is not a major event and does not provide any information about the company's overall performance.

Positives

• The increased stake by a key insider like Joshua Kushner could signal confidence in the company's future prospects.
• The purchases were made in accordance with Rule 10b-18, indicating compliance with trading regulations.

Risks

• The document does not provide any information about the company's overall financial health or future performance.
• The purchases could be for a variety of reasons and may not necessarily indicate a positive outlook for the company.

Industry Context

This filing is a routine disclosure of insider trading activity and does not provide specific insights into the broader healthcare industry or competitive landscape.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and this filing is consistent with standard reporting requirements.
• The purchases were made in accordance with Rule 10b-18, which is a common practice for insiders making open market purchases.

Stakeholder Impact

• The increased insider ownership could be viewed positively by shareholders, potentially increasing confidence in the company.

Key Dates

Keywords

Oscar Health, Joshua Kushner, insider trading, Class A Common Stock, share purchase, Thrive Capital Partners, Claremount VII Associates, Rule 10b-18